EQUASENS (EQS.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:EQS - FR0012882389 - Common Stock
44.45 EUR
+0.85 (+1.95%)
Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 11 industry peers in the Health Care Technology industry. EQS has an excellent profitability rating, but there are some minor concerns on its financial health. EQS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year EQS was profitable.
In the past year EQS had a positive cash flow from operations.
Each year in the past 5 years EQS has been profitable.
In the past 5 years EQS always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of EQS (8.84%) is better than 72.73% of its industry peers.
EQS's Return On Equity of 15.79% is amongst the best of the industry. EQS outperforms 90.91% of its industry peers.
EQS has a better Return On Invested Capital (12.70%) than 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EQS is significantly above the industry average of 9.28%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROIC | 12.7% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
1.3 Margins
The Profit Margin of EQS (16.15%) is better than 81.82% of its industry peers.
In the last couple of years the Profit Margin of EQS has remained more or less at the same level.
With an excellent Operating Margin value of 19.80%, EQS belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Operating Margin of EQS has declined.
EQS's Gross Margin of 68.81% is in line compared to the rest of the industry. EQS outperforms 45.45% of its industry peers.
EQS's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% |
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), EQS is creating value.
The number of shares outstanding for EQS remains at a similar level compared to 1 year ago.
EQS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, EQS has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.06 indicates that EQS is not in any danger for bankruptcy at the moment.
EQS has a better Altman-Z score (4.06) than 72.73% of its industry peers.
EQS has a debt to FCF ratio of 0.98. This is a very positive value and a sign of high solvency as it would only need 0.98 years to pay back of all of its debts.
EQS has a Debt to FCF ratio of 0.98. This is in the better half of the industry: EQS outperforms 72.73% of its industry peers.
EQS has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
EQS has a better Debt to Equity ratio (0.09) than 63.64% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Altman-Z | 4.06 |
ROIC/WACC1.63
WACC7.77%
2.3 Liquidity
EQS has a Current Ratio of 1.29. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EQS (1.29) is comparable to the rest of the industry.
A Quick Ratio of 1.20 indicates that EQS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.20, EQS is in line with its industry, outperforming 45.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.07%.
EQS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.12% yearly.
The Revenue has been growing slightly by 4.45% in the past year.
The Revenue has been growing slightly by 6.45% on average over the past years.
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
3.2 Future
EQS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.63% yearly.
EQS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.74% yearly.
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.60, the valuation of EQS can be described as rather expensive.
72.73% of the companies in the same industry are more expensive than EQS, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.59. EQS is valued slightly cheaper when compared to this.
EQS is valuated correctly with a Price/Forward Earnings ratio of 14.04.
81.82% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of EQS to the average of the S&P500 Index (24.03), we can say EQS is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.6 | ||
| Fwd PE | 14.04 |
4.2 Price Multiples
EQS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. EQS is cheaper than 63.64% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EQS indicates a somewhat cheap valuation: EQS is cheaper than 72.73% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.16 | ||
| EV/EBITDA | 9.3 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of EQS may justify a higher PE ratio.
A more expensive valuation may be justified as EQS's earnings are expected to grow with 18.63% in the coming years.
PEG (NY)1.43
PEG (5Y)3.63
EPS Next 2Y17.52%
EPS Next 3Y18.63%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.86%, EQS has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.30, EQS has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 1.88, EQS pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.86% |
5.2 History
On average, the dividend of EQS grows each year by 8.00%, which is quite nice.
Dividend Growth(5Y)8%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
EQS pays out 51.75% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP51.75%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPA:EQS (12/24/2025, 7:00:00 PM)
44.45
+0.85 (+1.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners11.63%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap674.31M
Revenue(TTM)224.73M
Net Income(TTM)36.30M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.86% |
Yearly Dividend1.25
Dividend Growth(5Y)8%
DP51.75%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.76%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.6 | ||
| Fwd PE | 14.04 | ||
| P/S | 3 | ||
| P/FCF | 18.16 | ||
| P/OCF | 13.97 | ||
| P/B | 2.93 | ||
| P/tB | 8.44 | ||
| EV/EBITDA | 9.3 |
EPS(TTM)2.39
EY5.38%
EPS(NY)3.17
Fwd EY7.12%
FCF(TTM)2.45
FCFY5.51%
OCF(TTM)3.18
OCFY7.16%
SpS14.81
BVpS15.16
TBVpS5.27
PEG (NY)1.43
PEG (5Y)3.63
Graham Number28.55
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.84% | ||
| ROE | 15.79% | ||
| ROCE | 15.59% | ||
| ROIC | 12.7% | ||
| ROICexc | 17.92% | ||
| ROICexgc | 69.44% | ||
| OM | 19.8% | ||
| PM (TTM) | 16.15% | ||
| GM | 68.81% | ||
| FCFM | 16.53% |
ROA(3y)11.42%
ROA(5y)11.3%
ROE(3y)20.52%
ROE(5y)21.51%
ROIC(3y)15.18%
ROIC(5y)16.08%
ROICexc(3y)19.36%
ROICexc(5y)21.38%
ROICexgc(3y)50.59%
ROICexgc(5y)62.81%
ROCE(3y)18.64%
ROCE(5y)19.75%
ROICexgc growth 3Y-25.09%
ROICexgc growth 5Y-9.54%
ROICexc growth 3Y-15.77%
ROICexc growth 5Y-10.18%
OM growth 3Y-8.16%
OM growth 5Y-4.74%
PM growth 3Y-6.19%
PM growth 5Y-1.37%
GM growth 3Y-0.25%
GM growth 5Y0.16%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.09 | ||
| Debt/FCF | 0.98 | ||
| Debt/EBITDA | 0.33 | ||
| Cap/Depr | 69.34% | ||
| Cap/Sales | 4.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 79.71% | ||
| Profit Quality | 102.29% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 4.06 |
F-Score7
WACC7.77%
ROIC/WACC1.63
Cap/Depr(3y)96.13%
Cap/Depr(5y)118.08%
Cap/Sales(3y)6.18%
Cap/Sales(5y)7.08%
Profit Quality(3y)94.47%
Profit Quality(5y)93.6%
High Growth Momentum
Growth
EPS 1Y (TTM)-14.07%
EPS 3Y-2.55%
EPS 5Y5.12%
EPS Q2Q%0.43%
EPS Next Y13%
EPS Next 2Y17.52%
EPS Next 3Y18.63%
EPS Next 5YN/A
Revenue 1Y (TTM)4.45%
Revenue growth 3Y3.93%
Revenue growth 5Y6.45%
Sales Q2Q%7.39%
Revenue Next Year9.72%
Revenue Next 2Y9.5%
Revenue Next 3Y5.96%
Revenue Next 5Y7.74%
EBIT growth 1Y-8.02%
EBIT growth 3Y-4.55%
EBIT growth 5Y1.4%
EBIT Next Year59.12%
EBIT Next 3Y27.46%
EBIT Next 5YN/A
FCF growth 1Y-36.73%
FCF growth 3Y-1.08%
FCF growth 5Y8.7%
OCF growth 1Y-31.7%
OCF growth 3Y0.02%
OCF growth 5Y3.18%
EQUASENS / EQS.PA FAQ
What is the ChartMill fundamental rating of EQUASENS (EQS.PA) stock?
ChartMill assigns a fundamental rating of 6 / 10 to EQS.PA.
What is the valuation status for EQS stock?
ChartMill assigns a valuation rating of 5 / 10 to EQUASENS (EQS.PA). This can be considered as Fairly Valued.
What is the profitability of EQS stock?
EQUASENS (EQS.PA) has a profitability rating of 7 / 10.
What is the expected EPS growth for EQUASENS (EQS.PA) stock?
The Earnings per Share (EPS) of EQUASENS (EQS.PA) is expected to grow by 13% in the next year.
Can you provide the dividend sustainability for EQS stock?
The dividend rating of EQUASENS (EQS.PA) is 6 / 10 and the dividend payout ratio is 51.75%.